Fund Holdings — Euclidean Capital LLC

Total Portfolio Value
$736.72M
Total Bought
$26.20M
Total Sold
$168.43M
Net Transaction
-$142.23M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
VANGUARD INTL EQUITY INDEX F507,6001,013,434+505,83431,97958,1817.90%+26,202
SURROZEN INC(SRZN)87,69687,69601,0511,2580.17%+208
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64303,9153,9680.54%+53
SURROZEN INC(SRZN)170,833170,8330240.00%+2
RAPT THERAPEUTICS INC657,899657,89901,3221,0390.14%-283
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70501,9601,4520.20%-508
ORIC PHARMACEUTICALS INC(ORIC)989,410989,410010,1417,9851.08%-2,157
23ANDME HOLDING CO10,243,1220-10,243,1223,5850—-3,585
ALECTOR INC1,307,8581,307,85806,0952,4720.34%-3,623
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,761014,6527,4281.01%-7,224
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440141,944127,66017.33%-14,284
SPDR S&P 500 ETF TR(SPY)1,202,804896,254-306,550690,121525,27771.30%-164,844
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q4 2024 | TickerTrail